Scrum is commonplace in the software industry, but
its ideas and principles can be applied to other domains and contexts. Can the
ideas of Scrum help Biotech firms deliver more value, whilst navigating the
complexities of innovation? Can Scrum work in an environment where experiments
take time, failure is likely, partnerships are proliferating, and roles are
highly specialized?
And will
scientists actually accept this new way of working?
In this webinar Dave West CEO of Scrum.org talks to
Tyson Bertmaring, MBA, Head of Partner Success at Dyno Therapeutics, and Matt
Abbinanti, Ph.D., Senior Program Manager at CRISPR Therapeutics on how Scrum master course in Chennai
works in Biotech.
About Our
Speakers
Matt Abbinanti,
Ph.D., Senior Program Manager at CRISPR Therapeutics
After a postdoc studying the electrophysiological
changes in spinal neurons after spinal cord injury, Matt entered the biotech
industry as a scientist for BioAxone Biosciences. Later, as Director of
Research and Project Management at BioAxone, he was responsible for leading the
preclinical development of small-molecule Rho kinase inhibitors from discovery
stage through IND-enabling studies for the treatment of cavernous angioma,
neurotrauma, and glaucoma. He made the transition to Program Management at
CRISPR Therapeutics in early 2019, facilitating the installation of the Scrum
framework for a high-performing research team and managing multiple alliances
and research-stage programs.
Tyson
Bertmaring, MBA, Head of Partner Success at Dyno Therapeutics
Tyson Bertmaring began his career as a United States
Air Force officer leading teams across diverse environments, spanning from
nuclear deterrence to R&D. Since departing active duty, Tyson has
transitioned those experiences to serve R&D teams across both large and
small biotech companies and alliances. He is passionate about experimenting
with Scrum to realize the joy and achievement of others through fulfilling
teamwork. Tyson’s current experiment is
enterprise wide at Dyno Therapeutics, a biotech startup.
Dave West, CEO,
Scrum.org
Dave is the CEO at Scrum.org. He is a frequent
keynote at major industry conferences and is a widely published author of
articles and research reports, along with his acclaimed book: Head First
Object-Oriented Analysis and Design, that helped define new software modeling
and application development processes. He led the development of the Rational
Unified Process (RUP) for IBM/Rational. After IBM/Rational, West returned to
consulting and managed Ivar Jacobson Consulting for North America. Then as VP,
research director Forrester research where he ran the software development and
delivery practice. Prior to joining Scrum.org he was Chief Product Officer at
Tasktop where he was responsible for product management, engineering and
architecture.
Resource:
https://www.scrum.org/resources/biotech-and-scrum-rethinking-how-biotech-innovates-21st-century
0 comments:
Post a Comment